Global Reach of Direct-to-Consumer Advertising Using Social Media for Illicit Online Drug Sales

Background Illicit or rogue Internet pharmacies are a recognized global public health threat that have been identified as utilizing various forms of online marketing and promotion, including social media. Objective To assess the accessibility of creating illicit no prescription direct-to-consumer advertising (DTCA) online pharmacy social media marketing (eDTCA2.0) and evaluate its potential global reach. Methods We identified the top 4 social media platforms allowing eDTCA2.0. After determining applicable platforms (ie, Facebook, Twitter, Google+, and MySpace), we created a fictitious advertisement advertising no prescription drugs online and posted it to the identified social media platforms. Each advertisement linked to a unique website URL that consisted of a site error page. Employing Web search analytics, we tracked the number of users visiting these sites and their location. We used commercially available Internet tools and services, including website hosting, domain registration, and website analytic services. Results Illicit online pharmacy social media content for Facebook, Twitter, and MySpace remained accessible despite highly questionable and potentially illegal content. Fictitious advertisements promoting illicit sale of drugs generated aggregate unique user traffic of 2795 visits over a 10-month period. Further, traffic to our websites originated from a number of countries, including high-income and middle-income countries, and emerging markets. Conclusions Our results indicate there are few barriers to entry for social media–based illicit online drug marketing. Further, illicit eDTCA2.0 has globalized outside US borders to other countries through unregulated Internet marketing.

[1]  Separating online piracy from counterfeit medicines: The need for policy reform and a call to action , 2012 .

[2]  Online Availability and Safety of Drugs in Shortage: A Descriptive Study of Internet Vendor Characteristics , 2012, Journal of medical Internet research.

[3]  A. Brenner Twitter Use 2012 , 2012 .

[4]  T. Mackey,et al.  Vaccine shortages and suspect online pharmacy sellers. , 2012, Vaccine.

[5]  Sara Rubinelli,et al.  “Save 30% if you buy today”. Online pharmacies and the enhancement of peripheral thinking in consumers , 2010, Pharmacoepidemiology and drug safety.

[6]  T. Mackey,et al.  Reforming direct-to-consumer advertising , 2011, Nature Biotechnology.

[7]  Bryan A Liang,et al.  Direct-to-consumer advertising with interactive internet media: global regulation and public health issues. , 2011, JAMA.

[8]  S. Morgan,et al.  Twelve Years' Experience with Direct-to-Consumer Advertising of Prescription Drugs in Canada: A Cautionary Tale , 2009, PloS one.

[9]  T. Mackey,et al.  Suspect online sellers and contraceptive access. , 2012, Contraception.

[10]  T. Mackey,et al.  Searching for Safety: Addressing Search Engine, Website, and Provider Accountability for Illicit Online Drug Sales , 2009, American Journal of Law & Medicine.

[11]  T. Mackey,et al.  The global counterfeit drug trade: patient safety and public health risks. , 2011, Journal of pharmaceutical sciences.

[12]  S. Majumdar,et al.  Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study , 2008, BMJ : British Medical Journal.

[13]  Kathryn Zickuhr,et al.  65% of Online Adults Use Social Networking Sites , 2011 .

[14]  Bryan A Liang,et al.  Prevalence and Global Health Implications of Social Media in Direct-to-Consumer Drug Advertising , 2011, Journal of medical Internet research.

[15]  Lawrence Fulton,et al.  Dirt Cheap and Without Prescription: How Susceptible are Young US Consumers to Purchasing Drugs From Rogue Internet Pharmacies? , 2010, Journal of medical Internet research.

[16]  T. Mackey,et al.  Oncology and the Internet: regulatory failure and reform. , 2012, Journal of oncology practice.

[17]  C. Jordens,et al.  Direct‐to‐consumer advertising under the radar: the need for realistic drugs policy in Australia , 2007, Internal medicine journal.